Leo Veenman Selected Research

Leo Veenman Research Topics

Disease

11	Neoplasms (Cancer) 04/2017 - 08/2004
8	Glioblastoma (Glioblastoma Multiforme) 04/2017 - 01/2008
5	Glioma (Gliomas) 08/2012 - 08/2004
4	Brain Injuries (Brain Injury) 10/2020 - 12/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 06/2008
2	Inflammation (Inflammations) 10/2020 - 05/2020
2	Cognitive Dysfunction 10/2020 - 12/2017
2	Mouth Neoplasms (Oral Cancer) 03/2015 - 05/2010
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2020
1	Stroke (Strokes) 10/2020
1	Virus Diseases (Viral Diseases) 10/2020
1	Parkinson Disease (Parkinson's Disease) 10/2020
1	Multiple Sclerosis 10/2020
1	Alzheimer Disease (Alzheimer's Disease) 10/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2020
1	Infections 10/2020
1	Fibrosis (Cirrhosis) 05/2020
1	Hyperglycemia 05/2020
1	Insulin Resistance 05/2020
1	Obesity 05/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Neuroinflammatory Diseases 01/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2017
1	Infarction (Infarctions) 12/2017
1	Carcinogenesis 04/2017
1	Leukemia 05/2014
1	Hyperammonemia 01/2014
1	Necrosis 08/2013
1	Brain Neoplasms (Brain Tumor) 08/2012
1	Tongue Neoplasms (Tongue Neoplasm) 05/2010
1	Hypoxia (Hypoxemia) 06/2009
1	Colorectal Neoplasms (Colorectal Cancer) 11/2008
1	Ischemia 06/2006

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2008
9	LigandsIBA 01/2020 - 08/2004
3	2-(2-chlorophenyl)quinazolin-4-yl dimethylcarbamateIBA 01/2020 - 12/2017
3	PK 11195 (PK11195)IBA 01/2020 - 01/2008
3	Antineoplastic Agents (Antineoplastics)IBA 05/2014 - 11/2008
3	GABA-A Receptors (GABA(A) Receptor)IBA 11/2008 - 08/2004
2	SmokeIBA 03/2015 - 05/2010
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2008 - 01/2008
1	CholesterolIBA 10/2020
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020
1	Estrogen ReceptorsIBA 10/2020
1	CalciumIBA 10/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2020
1	Raloxifene Hydrochloride (Evista)FDA Link 10/2020
1	Biological ProductsIBA 10/2020
1	Transaminases (Aminotransferases)IBA 05/2020
1	fucoidanIBA 05/2020
1	AntioxidantsIBA 05/2020
1	Polysaccharides (Glycans)IBA 05/2020
1	XenobioticsIBA 05/2020
1	SirtuinsIBA 05/2020
1	etifoxineIBA 01/2020
1	TSPO ligand MGV-1IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 12/2017
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2017
1	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2014
1	protoporphyrin IXIBA 08/2013
1	ElementsIBA 05/2013
1	EnzymesIBA 08/2012
1	Glutamic Acid (Glutamate)FDA Link 08/2012
1	Antisense RNA (Anti-Sense RNA)IBA 08/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 08/2012
1	RNA (Ribonucleic Acid)IBA 08/2012
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2012
1	AcidsIBA 08/2012
1	Small Interfering RNA (siRNA)IBA 07/2012
1	erucylphospho- N,N,N- trimethylpropylammoniumIBA 07/2010
1	erucylphosphohomocholine ErPC3IBA 07/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2010
1	cobaltous chloride (cobalt(II)chloride)IBA 06/2009
1	4'-chlorodiazepamIBA 12/2008
1	Neuroprotective AgentsIBA 12/2008
1	N,N- di- n- hexyl- 2- (4- fluorophenyl)indole- 3- acetamideIBA 11/2008
1	Pharmaceutical PreparationsIBA 06/2008
1	Antipsychotic Agents (Antipsychotics)IBA 01/2008
1	Sulpiride (neogama)IBA 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2008
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 01/2008
1	Progesterone FDA LinkGeneric 01/2008
1	Voltage-Dependent Anion ChannelsIBA 01/2008
1	Mitochondrial Permeability Transition PoreIBA 01/2008
1	Clozapine (Clozaril)FDA LinkGeneric 01/2008
1	Adenine NucleotidesIBA 01/2008
1	Coloring Agents (Dyes)IBA 01/2008
1	SSR180575IBA 06/2006
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 07/2005
1	isoquinolineIBA 07/2005
1	Carrier Proteins (Binding Protein)IBA 07/2005

Therapy/Procedure

1	Therapeutics 01/2019
1	Drug Therapy (Chemotherapy) 05/2014